Jun 2026 (Q2 FY26) — Jul 29, 2026
Moelis & Company Q2 FY26 — Record Revenues and Strong Pipeline
Read the full callMoelis & Company (MC) earnings
- Jun 2026 (Q2 FY26)
- Dec 2025
Moelis & Company earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Price
$53.07 −2.71% · −$1.48
Performance −21.6% 1Y
1Y: $67.7 on 17 Oct 2025 → $53.07. High $77.75 (15 Jan 2026), low $51.38 (12 Mar 2026).
- Previous close
- $54.55
- 52-week range
- $51.38 – $77.75
- One year
- −22.69%
Overview
- Symbol
- MC
- Sector
- Financials
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — Apr 29, 2026
Moelis & Company Q1 FY26 — Record Revenue and Strong Pipeline
Read the full callEvery analysed call
Moelis & Company earnings calls (MC)
Financials
What the filings say
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Reserves | -238 | -324 | -421 | -535 | -561 | -768 | -822 | -801 |
| Total liabilities | 543 | 678 | 752 | 1,077 | 758 | 817 | 900 | 1,060 |
| Fixed assets | 13 | 14 | 50 | 59 | 57 | 64 | 65 | 90 |
| Investments | 144 | 213 | 212 | 263 | 265 | — | — | — |
| Total assets | 914 | 1,072 | 1,196 | 1,556 | 1,217 | 1,180 | 1,379 | 1,741 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 391 | 209 | 429 | 937 | 33 | 158 | 427 | 576 |
| Cash from investing | 9 | -52 | -40 | -17 | -11 | 49 | 17 | -196 |
| Cash from financing | -352 | -253 | -352 | -603 | -327 | -229 | -215 | -284 |
| Net cash flow | 48 | -93 | 35 | 318 | -313 | -20 | 226 | 96 |
| Capital expenditure | -7 | -6 | -41 | -16 | -6 | -17 | -12 | -36 |
| Free cash flow | 384 | 203 | 389 | 921 | 27 | 142 | 415 | 540 |
Insider filings
62 filings between Oct 30, 2025 and Sep 17, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$638.1K
3 sales by 2 insiders
Compensation
not trading decisions- 46
- Award — granted as compensation
- 7
- Option exercise — converted options into shares
- 6
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| WATANABE OSAMU R. | — | $508.2K | Aug 4, 2026 |
| Shropshire Kenneth | — | $129.9K | Aug 27, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Shropshire Kenneth Director | Award | 19 | — |
| Sep 17, 2026 | Worrell Laila Director | Award | 19 | — |
| Sep 17, 2026 | Barker Thorold Director | Award | 17 | — |
| Sep 17, 2026 | Worrell Laila Director | Award | 18 | — |
| Sep 17, 2026 | Shropshire Kenneth Director | Award | 20 | — |
| Sep 17, 2026 | Shropshire Kenneth Director | Award | 2 | — |
| Sep 17, 2026 | Barker Thorold Director | Award | 18 | — |
| Sep 17, 2026 | Worrell Laila Director | Award | 19 | — |
| Sep 17, 2026 | Mirrer Louise Director | Award | 19 | — |
| Sep 17, 2026 | Mirrer Louise Director | Award | 18 | — |
| Aug 27, 2026 | Shropshire Kenneth Director | Sale | 1,881 | $129.9K |
| Aug 4, 2026 | WATANABE OSAMU R. General Counsel, Secretary | Sale | 4,850 | $336.1K |
| Jul 1, 2026 | Barker Thorold Director | Award | 1,545 | — |
| Jul 1, 2026 | Shropshire Kenneth Director | Award | 200 | — |
| Jul 1, 2026 | Mirrer Louise Director | Award | 1,623 | — |
| Jul 1, 2026 | Worrell Laila Director | Award | 1,777 | — |
| Jul 1, 2026 | Worrell Laila Director | Award | 1,623 | — |
| Jul 1, 2026 | Shropshire Kenneth Director | Award | 1,700 | — |
| Jun 18, 2026 | Mirrer Louise Director | Award | 0 | — |
| Jun 18, 2026 | Mirrer Louise Director | Award | 12 | — |
| Jun 18, 2026 | Shropshire Kenneth Director | Award | 1 | — |
| Jun 18, 2026 | Shropshire Kenneth Director | Award | 18 | — |
| Jun 18, 2026 | Shropshire Kenneth Director | Award | 21 | — |
| Jun 18, 2026 | Worrell Laila Director | Award | 5 | — |
| Jun 18, 2026 | Mirrer Louise Director | Award | 17 | — |
| Jun 18, 2026 | Worrell Laila Director | Award | 17 | — |
| Jun 18, 2026 | Barker Thorold Director | Award | 16 | — |
| Jun 18, 2026 | Worrell Laila Director | Award | 20 | — |
| Mar 26, 2026 | Mirrer Louise Director | Award | 15 | — |
| Mar 26, 2026 | Worrell Laila Director | Award | 11 | — |
| Mar 26, 2026 | Shropshire Kenneth Director | Award | 1 | — |
| Mar 26, 2026 | Shropshire Kenneth Director | Award | 21 | — |
| Mar 26, 2026 | Shropshire Kenneth Director | Award | 25 | — |
| Mar 26, 2026 | Worrell Laila Director | Award | 20 | — |
| Mar 26, 2026 | Worrell Laila Director | Award | 24 | — |
| Mar 26, 2026 | Barker Thorold Director | Award | 19 | — |
| Mar 26, 2026 | Mirrer Louise Director | Award | 20 | — |
| Mar 26, 2026 | Mirrer Louise Director | Award | 0 | — |
| Feb 19, 2026 | Pilcher Ciafone Katherine Chief Operating Officer | Tax withheld | 850 | $53.4K |
| Feb 19, 2026 | Pilcher Ciafone Katherine Chief Operating Officer | Option exercise | 4,885 | — |
| Feb 19, 2026 | Cantor Eric Vice Chairman, MD | Option exercise | 32,368 | — |
| Feb 19, 2026 | Cantor Eric Vice Chairman, MD | Tax withheld | 14,225 | $892.3K |
| Feb 19, 2026 | Riehl Nick Principal Accounting Officer | Tax withheld | 25 | $1.6K |
| Feb 19, 2026 | WATANABE OSAMU R. General Counsel, Secretary | Sale | 2,765 | $172.1K |
| Feb 19, 2026 | Riehl Nick Principal Accounting Officer | Option exercise | 61 | — |
| Feb 19, 2026 | Callesano Christopher Chief Financial Officer | Tax withheld | 1,114 | $69.9K |
| Feb 19, 2026 | WATANABE OSAMU R. General Counsel, Secretary | Tax withheld | 1,604 | $100.6K |
| Feb 19, 2026 | WATANABE OSAMU R. General Counsel, Secretary | Option exercise | 9,219 | — |
| Feb 19, 2026 | Callesano Christopher Chief Financial Officer | Option exercise | 2,179 | — |
| Dec 5, 2025 | Cantor Eric Vice Chairman, MD | Tax withheld | 668 | $44.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Moelis & Co
Free account. Everything above stays public.
Write why you follow Moelis & Co and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading